Press release
The Acquired Hemolytic Anemia market to witness an incremental CAGR between 2020 and 2030
Hemolytic anemia is a diseased condition characterized by premature destruction of red blood cells (RBCs) and their removal from the blood circulatory system before their life span is over. Red blood cells also known as erythrocytes are disk like structures that carry oxygen from lungs to body organs and help in removing carbon dioxide from the body. Usually red blood cells (RBCs) have a normal life span of 120 before they are removed from the blood stream by spleen. Red blood cells are produced by bone marrow. In people suffering from acquired (autoimmune) hemolytic anemia, bone marrows are unable to produce enough RBCs to meet body’s demand.For more insights into the Market, request a sample of this report @ https://www.persistencemarketresearch.com/samples/19732
Acquired (autoimmune) hemolytic anemia is non-genetic in nature and usually occurs when the body’s own immune system destroys its healthy tissues against invading organisms such as lymphocytes and antibodies. Acquired (autoimmune) hemolytic anemia generally occurs as a result or in conjunction with some other medical conditions. This condition rarely occurs alone. Acquired (autoimmune) hemolytic anemia can be classified as warm antibody hemolytic anemia and cold antibody hemolytic anemia. In warm antibody hemolytic anemia, auto-antibodies attach with the red blood cells and kill them at temperature higher than the body temperature; conversely, in cold antibody hemolytic anemia self-generated antibodies kill red blood cells at a temperature below the body temperature.
For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/19732
Diagnosis involves a range of blood tests such as hemoglobin and hematocrit test, bilirubin test, serum haptoglobin test and reticulocyte count. If the ratio is high, there is likeliness of hemolytic anemia. Coombs test is another key diagnostic method for acquired (autoimmune) hemolytic anemia in which the amount of certain antibodies is determined in order to check if it is higher than normal. Treatment is based on three major aims, preventing the destruction of RBCs, increasing the RBCs count and treating the origin of illness. Blood transfusion, medications, plasmapheresis and surgeries are among major treatment options. Prednisone, rituximab, hydroxyurea and cyclosporine are some drugs that are usually prescribed for treating acquired (autoimmune) hemolytic anemia.
To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/19732
There are no exact incidence and prevalence statistics are available regarding the acquired (autoimmune) hemolytic anemia. According to sources from Elsevier, Inc. the incidence rate of all types of acquired (autoimmune) hemolytic anemias range from one new case per 100,000 general population to 300,000 per year. Though the prevalence is not so high, severity of the condition will play a key role in driving the market growth. The market will also be driven by unmet medical needs as there is no standard medicines available for treating acquired hemolytic anemia. Many companies are conducting clinical trials in order to introduce effective medicines for acquired hemolytic anemia. Some major pharmaceutical companies and research institutions that are engaged in the development, manufacturing and marketing of drugs for this market include Novartis AG, Sanofi, Centre Hospitalier Universitaire Dijon, Institute of Hematology & Blood Diseases Hospital, Hoffmann-La Roche, National Cancer Institute (NCI), Agios Pharmaceuticals, Inc., Octapharma Pharmazeutika Produktionsges.m.b.H., National Heart, Lung, and Blood Institute (NHLBI) and Baxter Healthcare Corporation.
Geographically, the acquired (autoimmune) hemolytic anemia market has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). Globally, the market is led by North America, followed by Europe, Asia-Pacific and Rest of the World (RoW). High level of awareness, high per capita income and well established reimbursement scenario are among the major factors responsible for North America’s leading position in the acquired (autoimmune) hemolytic anemia market.
Contact Us:
305 Broadway
7th Floor
New York City, NY 10007
United States
U.S.A - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PersistenceMarketResearch.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Acquired Hemolytic Anemia market to witness an incremental CAGR between 2020 and 2030 here
News-ID: 2203427 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for RBCs
Creative Diagnostics Introduces New Anti-RBC Antibodies for Enhanced Blood Produ …
Creative Diagnostics launches Anti-RBC antibodies for impurity cleansing of blood products and the diagnosis of RBC-affected autoimmune diseases.
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, announces the launch of its new line of Anti-RBC antibodies [https://www.creative-diagnostics.com/anti-rbc-antibodies-for-impurity-cleansing-and-research-of-rbcs-affected-autoimmune-diseases-diagnosis.htm] for impurity cleansing of blood products and the diagnosis of RBC-affected autoimmune diseases. These innovative products offer exceptional performance and can be used in a variety of scientific applications,…
Creative Diagnostics Launches Reliable Hemagglutination Assay for Virus and Anti …
Creative Diagnostics launches Hemagglutination Assay services for effective virus and antibody detection.
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its Hemagglutination Assay [https://antiviral.creative-diagnostics.com/hemagglutination-assay-ha.html] (HA) services for effective virus and antibody detection. The new anti-virus testing solution offers a valuable tool for researchers working on influenza virus characterization, vaccine development, and general viral diagnostics.
Certain viruses agglutinate red blood…
Gel Card Tests Market Revenue, Insights, Overview, Outlook, Analysis | Valuates …
Gel Card Tests Market
A gel card test, also known as a gel agglutination test, is a type of diagnostic test used in immunohematology to determine blood compatibility, blood group typing, and the presence of specific antibodies in blood samples. Gel card tests utilize gel matrix technology to simplify and expedite the process of performing multiple blood tests simultaneously in a single platform.
According to new survey, global Gel Card Tests market…
Acquired (Autoimmune) Hemolytic Anemia Market Novartis, Sanofi, Hoffmann-La Roch …
Hemolytic anemia is a diseased condition characterized by premature destruction of red blood cells (RBCs) and their removal from the blood circulatory system before their life span is over. Red blood cells also known as erythrocytes are disk like structures that carry oxygen from lungs to body organs and help in removing carbon dioxide from the body. Usually red blood cells (RBCs) have a normal life span of 120 before…
Complete Blood Count (CBC) Market Analysis Reveals explosive growth by 2023 | An …
The demand for Complete Blood Count (CBC) Market is anticipated to be high for the next few years. By considering this demand we provide latest Complete Blood Count (CBC) Market Report which gives complete industry analysis, market outlook, size, growth and forecast till 2023. This report will assist in analyzing the current and future business trends, sales and revenue forecasts.
Global Complete Blood Count (CBC) Market Overview:
This report studies the Global…
Nanobots Pave Way For The Development Of Artificial Antibodies, Artificial RBCs …
The emerging technology of nanobots offers better chances of fighting chronic diseases such as cancer. Moreover, further developments in nanomedicine market can create opportunities such as the development of artificial antibodies and artificial RBCs and WBCs.
Nanomedicine is a domain of medicine that utilizes the knowledge of nanotechnology to prevent and treat severe diseases such as cancer and heart diseases. The recent advances in nanotechnology have enabled doctors to use…